The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. The market is experiencing rapid expansion due to increasing adoption of genomics technologies across healthcare, biotechnology, pharmaceuticals, and life science research applications. The growth is strongly...

The global Liquid Biopsy Market size was estimated at USD 13.60 billion in 2025 and is projected to reach USD 32.57 billion by 2033, growing at a CAGR of 11.52% from 2026 to 2033. The market is experiencing significant growth due to the rising prevalence of cancer worldwide, rapid advancements in cancer diagnostics, and the increasing preference for minimally invasive testing methods....

The global Personalized Testing & Supplements Market was valued at USD 13.6 billion in 2025 and is projected to grow from USD 15.7 billion in 2026 to USD 46.3 billion by 2033, registering a remarkable CAGR of 16.7% from 2026 to 2033. The market is experiencing rapid expansion as consumers increasingly seek personalized health solutions tailored to their unique genetics,...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

As we enter 2026, the global clinical landscape is being redefined by deep-learning architectures that identify pathogenic variants with 99% accuracy. In North America and the European Union, the adoption of Artificial Intelligence In Genomics Market protocols has become a mandatory component of pediatric rare disease diagnostics. This shift is particularly evident in medical hubs...

The FFPE Tissue Samples Market plays a crucial role in advancing disease research and clinical diagnostics due to its ability to preserve tissue morphology for long periods while enabling molecular analysis. In recent years, researchers and medical professionals have increasingly relied on FFPE specimens to explore genetic, protein, and cellular characteristics of diseases such as cancer. This...

The growing prevalence of bile duct cancer and the increasing demand for advanced oncology treatments are significantly contributing to the expansion of the global therapeutics market. Rising investments in cancer research, improved diagnostic technologies, and the introduction of targeted therapies are transforming the treatment landscape for cholangiocarcinoma, commonly known as bile duct...

Clinical genetic testing adoption across China's extensive hospital network is approaching what many industry observers characterize as an inflection point in 2026, as oncology genomic profiling, reproductive genetic testing, rare disease genetic diagnosis, and pharmacogenomic testing transition from specialized academic medical center services to mainstream clinical tools deployed across...

Global Genomics Market Size, Share, Industry Analysis & Forecast 2033 Introduction The Global Genomics Market is expanding rapidly as advancements in sequencing technologies and bioinformatics continue to transform modern healthcare and life sciences research. Genomics involves the study of genes and their functions, enabling scientists and healthcare professionals to better...

The North America PARP inhibitor biomarkers testing product market is experiencing significant expansion due to growing awareness of personalized medicine, increasing cancer incidence, and rapid advancements in molecular diagnostics. The region benefits from a well-established healthcare ecosystem, strong government support for cancer research, and widespread access to genomic testing...